22-42599706-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032311.5(POLDIP3):c.625C>T(p.His209Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000237 in 1,604,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032311.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POLDIP3 | ENST00000252115.10 | c.625C>T | p.His209Tyr | missense_variant | Exon 4 of 9 | 1 | NM_032311.5 | ENSP00000252115.5 | ||
ENSG00000289517 | ENST00000617178.5 | n.*1486C>T | non_coding_transcript_exon_variant | Exon 9 of 14 | 1 | ENSP00000482500.2 | ||||
ENSG00000289517 | ENST00000617178.5 | n.*1486C>T | 3_prime_UTR_variant | Exon 9 of 14 | 1 | ENSP00000482500.2 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000479 AC: 12AN: 250712Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135566
GnomAD4 exome AF: 0.0000241 AC: 35AN: 1452356Hom.: 0 Cov.: 30 AF XY: 0.0000429 AC XY: 31AN XY: 723184
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152216Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74372
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.625C>T (p.H209Y) alteration is located in exon 4 (coding exon 4) of the POLDIP3 gene. This alteration results from a C to T substitution at nucleotide position 625, causing the histidine (H) at amino acid position 209 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at